ALAR vs CGNT vs NTCT vs RDWR vs BCYC

For growth investors, Bicycle Therapeutics plc (BCYC) is the stronger pick with 105.

8% revenue growth year-over-year, versus -0. 8% for NetScout Systems, Inc. (NTCT). Alarum Technologies Ltd. (ALAR) offers the better valuation at 9. 4x trailing P/E, making it the more compelling value choice. Analysts rate Bicycle Therapeutics plc (BCYC) a "Buy" — based on 21 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Alarum Technologies Ltd.

(ALAR) is the cheapest at 9. 4x versus Radware Ltd. at 63. 0x. On forward P/E, NetScout Systems, Inc. is actually cheaper at 15. 9x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, NetScout Systems, Inc.

(NTCT) delivered a total return of +42. 9%, compared to -84. 6% for Bicycle Therapeutics plc (BCYC). Over 10 years, the gap is even starker: RDWR returned +164. 8% versus ALAR's -99. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Radware Ltd.

(RDWR) is the lower-risk stock at 0. 99β versus Alarum Technologies Ltd. 's 2. 01β — meaning ALAR is approximately 102% more volatile than RDWR relative to the S&P 500. On balance sheet safety, Bicycle Therapeutics plc (BCYC) carries a lower debt/equity ratio of 3% versus 16% for Cognyte Software Ltd. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Bicycle Therapeutics plc (BCYC) is pulling ahead at 105.

8% versus -0. 8% for NetScout Systems, Inc. (NTCT). On earnings-per-share growth, the picture is similar: Radware Ltd. grew EPS 221. 4% year-over-year, compared to -144. 4% for NetScout Systems, Inc.. Over a 3-year CAGR, BCYC leads at 71. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Alarum Technologies Ltd.

(ALAR) is the more profitable company, earning 18. 2% net margin versus -301. 7% for Bicycle Therapeutics plc — meaning it keeps 18. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALAR leads at 21. 1% versus -341. 3% for BCYC. At the gross margin level — before operating expenses — BCYC leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, NetScout Systems, Inc.

(NTCT) trades at 15. 9x forward P/E versus 46. 9x for Cognyte Software Ltd. — 31. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BCYC: 118. 2% to $10. 67.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Radware Ltd.

(RDWR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 99), +164. 8% 10Y return). Alarum Technologies Ltd. (ALAR) carries a higher beta of 2. 01 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (RDWR: +164. 8%, ALAR: -99. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (ALAR (Technology) and CGNT (Technology) and NTCT (Technology) and RDWR (Technology) and BCYC (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: ALAR is a small-cap high-growth stock; CGNT is a small-cap quality compounder stock; NTCT is a small-cap quality compounder stock; RDWR is a small-cap quality compounder stock; BCYC is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.